Clinical trial
Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal…
NCT00127114 · Johns Hopkins University, Other · Withdrawn
Key facts
| NCT number | NCT00127114 |
|---|---|
| Title | Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) |
| Official title | Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) |
| Lead sponsor | Johns Hopkins University, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dementia |
| Intervention type | Drug |
| Interventions | Amantadine, Placebo |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| Primary completion | Jul 26, 2007 |
| Completion | Jul 26, 2007 |
| First posted | Aug 5, 2005 |
| Last update posted | Aug 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: